USFDA report on Halol unit to be positive in long-term: Sun Pharma
December 19, 2016
Vadodara:Pharma major Sun Pharma has said the US health regulator’s audit report on its plant at Halol in Gujarat will have a positive impact on the company in the long-term.
The company’s Halol facility recently underwent an inspection by the US Food and Drug Administration (USFDA).
After the inspection, the American health regulator issued an observation letter to Sun Pharma.
“We have received the audit report of the Halol facility from the USFDA. I think, in the long-term this action will be positive for the company,” Sun Pharma MD Dilip Sanghvi told PTI on the sidelines of the 65th annual convocation of the Maharaja Sayajirao University over the weekend.
The inspection was completed on December 1 after which an observation letter was issued by the USFDA. However, the company has not disclosed the nature of observations.
PTI
Recent Stories
- Scooterist dies after being hit by AMTS bus; driver held
- Renovated war memorial 'Shraddhanjali Park' unveiled at Bhuj Military Station
- Strand Life Sciences Develops Prenatal Genomic Diagnostics Portfolio
- 265 candidates in fray for 25 Lok Sabha seats in Gujarat
- Mob attacks Hindu couple, attempts shop arson in Ochchan village
- Nilesh Kumbhani leaves Surat for vacation with family
- Power demand in Gujarat crosses 23,000 MW mark